The TDP-43 pathology may act as the primary cause of these diseases, while the presence of other pathologies induced by TDP-43 co-aggregation is associated with the neuropathological features that may worsen the clinical outcomes of ALS and FTLD patients. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.